S Marciano, M Dirchwolf, M C Torres, J Allevato, C García Dans, B García, F Pollarsky, L Gaite, E Sirotinsky, B Rios, M N Anselmo, M Peche, E Hurtado, L Haddad, A Narvaez, E Mauro, A Martinez, C Bellizzi, N Ratusnu, C D'Amico, S Arora, A Gadano
INTRODUCTION AND AIMS: Fibrosis staging in patients with nonalcoholic fatty liver disease (NAFLD) is carried out through the application of stepwise algorithms but there is little real-world data on their use. Our aim was to calculate the number of patients with NAFLD and indeterminate or high risk for fibrosis, assessed through noninvasive scores, that consequently underwent further staging evaluation. MATERIALS AND METHODS: A cross-sectional multicenter cohort study was conducted on patients with NAFLD evaluated by hepatologists within the time frame of June 1 and July 31, 2018...
October 21, 2021: Revista de Gastroenterología de México